MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
37.22 CAD
+0.45 (+1.22%)
We assign a fundamental rating of 6 out of 10 to MDA. MDA was compared to 13 industry peers in the Aerospace & Defense industry. Both the profitability and the financial health of MDA get a neutral evaluation. Nothing too spectacular is happening here. MDA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make MDA a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- In the past year MDA was profitable.
- MDA had a positive operating cash flow in the past year.
- MDA had positive earnings in 4 of the past 5 years.
- In the past 5 years MDA always reported a positive cash flow from operatings.
1.2 Ratios
- MDA's Return On Assets of 3.15% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
- MDA has a Return On Equity of 8.24%. This is in the better half of the industry: MDA outperforms 76.92% of its industry peers.
- MDA's Return On Invested Capital of 5.12% is on the low side compared to the rest of the industry. MDA is outperformed by 61.54% of its industry peers.
- MDA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is below the industry average of 8.00%.
- The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 7.40%, MDA is doing good in the industry, outperforming 76.92% of the companies in the same industry.
- MDA's Profit Margin has improved in the last couple of years.
- With a Operating Margin value of 9.86%, MDA is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
- MDA's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 24.62%, MDA is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
- In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDA is destroying value.
- The number of shares outstanding for MDA has been increased compared to 1 year ago.
- MDA has a better debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of 1.76, we must say that MDA is in the distress zone and has some risk of bankruptcy.
- MDA has a Altman-Z score of 1.76. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
- MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
- The Debt to FCF ratio of MDA (0.92) is better than 100.00% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.31, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.57
WACC9.03%
2.3 Liquidity
- A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
- MDA has a worse Current ratio (0.55) than 84.62% of its industry peers.
- MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDA has a Quick ratio (0.54) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
- MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
- The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
- MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 57.77%.
- Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
- Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.78% on average per year.
- Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.84% on average per year.
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 32.94, which means the current valuation is very expensive for MDA.
- 61.54% of the companies in the same industry are cheaper than MDA, based on the Price/Earnings ratio.
- MDA's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.32.
- Based on the Price/Forward Earnings ratio of 23.93, the valuation of MDA can be described as rather expensive.
- MDA's Price/Forward Earnings ratio is in line with the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 24.30. MDA is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.94 | ||
| Fwd PE | 23.93 |
4.2 Price Multiples
- MDA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MDA is more expensive than 69.23% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.08 | ||
| EV/EBITDA | 18.79 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of MDA may justify a higher PE ratio.
- MDA's earnings are expected to grow with 35.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y49.06%
EPS Next 3Y35.78%
5. Dividend
5.1 Amount
- MDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (1/21/2026, 7:00:00 PM)
37.22
+0.45 (+1.22%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.70B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.46
Price Target40.74 (9.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)3.25%
PT rev (3m)-6.95%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)1.46%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)-2.26%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.94 | ||
| Fwd PE | 23.93 | ||
| P/S | 3.18 | ||
| P/FCF | 10.08 | ||
| P/OCF | 6.39 | ||
| P/B | 3.54 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.79 |
EPS(TTM)1.13
EY3.04%
EPS(NY)1.56
Fwd EY4.18%
FCF(TTM)3.69
FCFY9.92%
OCF(TTM)5.82
OCFY15.65%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.31
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.76 |
F-Score6
WACC9.03%
ROIC/WACC0.57
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y49.06%
EPS Next 3Y35.78%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
Can you provide the valuation status for MDA SPACE LTD?
ChartMill assigns a valuation rating of 4 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the financial health of MDA SPACE LTD (MDA.CA) stock?
The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.
What is the earnings growth outlook for MDA SPACE LTD?
The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.